Page 2 - Pharma Intelligence News Today

The demand for biologic drugs continues to grow at a steady 12–14% annually. To keep up, biotech and biopharma developers are increasingly relying on outsourcing partners to meet both clinical and commercial research, development, and production needs.

Since U.S. Food and Drug Administration (FDA) Commissioner Dr. Robert Califf began his second tenure as the agency’s head in February 2022, he has made combating “misinformation” one of his top [...]

Gain insight into how small and mid-size pharma sponsors can successfully navigate the challenges of Japan's clinical, regulatory, and cultural...

Next-generation SaaS technology will enable study sponsors and CROs to better design, plan, and monitor clinical trials, from feasibility to start-up through enrollment NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE)

Learn why navigating the Japan's clinical, regulatory, and cultural environment can be a challenging endeavor for small and mid-size foreign...

/PRNewswire/ -- The COVID-19 pandemic led to a sudden surge in R&D activities across the world. Both small and large pharmaceutical and biotech companies were...

/PRNewswire/ -- The COVID-19 pandemic led to a sudden surge in R&D activities across the world. Both small and large pharmaceutical and biotech companies were...

A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 31st October – 4th November ...

/PRNewswire/ -- Norstella, a global leader with end-to-end solutions that smooth access to life-saving therapies for patients, has announced the completion of...

EQS-News: France Biotech / Key word(s): Conference The 4th edition of the HealthTech Innovation Days (HTID), in Paris, succeeded in bringing together key players of the European healthtech